# The Prospects of Electromagnetic Stimulation in Cartilage and Bone Tissue Engineering

**Authors:** Ivan V. Zhivodernikov, Stanislav Y. Ershov, Karina D. Goncharova, Tatiana V. Kirichenko, Yuliya V. Markina, Alexander M. Markin

PMC · DOI: 10.3390/cells15040325 · 2026-02-10

## TL;DR

Electromagnetic stimulation can boost the growth of cartilage and bone tissues by influencing stem cells and their signaling.

## Contribution

This paper reviews how electromagnetic fields enhance stem cell differentiation and exosome production for tissue repair.

## Key findings

- Electromagnetic fields stimulate osteogenic and chondrogenic differentiation of MSCs.
- Extracellular vesicles may mediate the effects of electromagnetic stimulation, enhancing regenerative properties.
- EMFs at 15 Hz and 2 mT increased chondrogenic markers in human bone-marrow MSCs.

## Abstract

What are the main findings?
Electromagnetic fields stimulate cell differentiation, in particular osteogenic and chondrogenic MSC differentiation.Extracellular vesicles can be considered as mediators of electromagnetic stimulation, suggesting that electrically stimulated cells may produce exosomes with enhanced regenerative properties.

Electromagnetic fields stimulate cell differentiation, in particular osteogenic and chondrogenic MSC differentiation.

Extracellular vesicles can be considered as mediators of electromagnetic stimulation, suggesting that electrically stimulated cells may produce exosomes with enhanced regenerative properties.

What are the implications of the main findings?
Electromagnetic stimulation is a complementary or alternative tool in the classical tissue engineering triad that includes cells, scaffolds, and biochemical stimuli for increasing chondro- and osteogenesis.

Electromagnetic stimulation is a complementary or alternative tool in the classical tissue engineering triad that includes cells, scaffolds, and biochemical stimuli for increasing chondro- and osteogenesis.

The achievements of regenerative medicine are based on methods of controlling stem cell division and differentiation. Electromagnetic fields stimulate cell differentiation by means of affecting calcium channels and cellular signaling. However, only a small part of the mechanisms underlying electromagnetic field effect on cells has been studied. The prospect of their use in tissue engineering as an addition or alternative to biochemical effects becomes clear in the course of numerous experiments. Electromagnetic stimulation enhances the effect of biochemical differentiation inducers and can cause the secretion of exosomes of special properties, which may serve as a therapeutic tool. For example, it has been shown that EMFs at 15 Hz and 2 mT increased the expression of chondrogenic differentiation markers SOX9 and COL2 in human bone-marrow MSCs by up to 3-fold (based on Parate et al.). Optimizing EMF parameters (e.g., 15–50 Hz, 1–2 mT) for specific cells and pathologies remains a key challenge of the studies in the field of tissue engineering. This review describes the electromagnetic field effect on the chondrogenic and osteogenic differentiation of MSCs of various origins, which is important for the musculoskeletal tissue recovery, as well as on inflammatory diseases in model animals.

## Linked entities

- **Genes:** SOX9 (SRY-box transcription factor 9) [NCBI Gene 6662], col-2 (Cuticle collagen 2) [NCBI Gene 177872]
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** Wnt5a (wingless-type MMTV integration site family, member 5A) [NCBI Gene 22418] {aka 8030457G12Rik, Wnt-5a}, Mmp13 (matrix metallopeptidase 13) [NCBI Gene 17386] {aka Clg, MMP-13, Mmp1}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, Acan (aggrecan) [NCBI Gene 58968] {aka Agc, Agc1}, VCL (vinculin) [NCBI Gene 7414] {aka CMD1W, CMH15, HEL114, MV, MVCL, VINC}, BGLAP (bone gamma-carboxyglutamate protein) [NCBI Gene 632] {aka BGP, OC, OCN}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, SOX9 (SRY-box transcription factor 9) [NCBI Gene 6662] {aka CMD1, CMPD1, ENH13, SRA1, SRXX2, SRXY10}, PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747] {aka FADK, FADK 1, FAK, FAK1, FRNK, PPP1R71}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Col2a1 (collagen, type II, alpha 1) [NCBI Gene 12824] {aka Col2, Col2a, Col2a-1, Del1, Dmm, Lpk}, Col2a1 (collagen type II alpha 1 chain) [NCBI Gene 25412] {aka CG2A1A, COLLII}, TRPC1 (transient receptor potential cation channel subfamily C member 1) [NCBI Gene 7220] {aka HTRP-1, TRP1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, Trpv4 (transient receptor potential cation channel, subfamily V, member 4) [NCBI Gene 66026] {aka Otrpc4, Vroac}, ACAN (aggrecan) [NCBI Gene 176] {aka AGC1, AGCAN, CSPG1, CSPGCP, MSK16, SEDK}, Mmp13 (matrix metallopeptidase 13) [NCBI Gene 171052], RHO (rhodopsin) [NCBI Gene 6010] {aka CSNBAD1, OPN2, RP4}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, TNFRSF11B (TNF receptor superfamily member 11b) [NCBI Gene 4982] {aka OCIF, OPG, PDB5, TR1}, Mir150 (microRNA 150) [NCBI Gene 387168] {aka Mirn150, mir-150, mmu-mir-150}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, SP7 (Sp7 transcription factor) [NCBI Gene 121340] {aka OI11, OI12, OSX, osterix}, TRPV4 (transient receptor potential cation channel subfamily V member 4) [NCBI Gene 59341] {aka BCYM3, CMT2C, HMSN2C, OTRPC4, SMAL, SPSMA}, RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860] {aka AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, Il1 (interleukin 1 complex) [NCBI Gene 111343] {aka Il-1}, CALM1 (calmodulin 1) [NCBI Gene 801] {aka CALML2, CAM2, CAM3, CAMB, CAMC, CAMI}, SPARC (secreted protein acidic and cysteine rich) [NCBI Gene 6678] {aka BM-40, OI17, ON, ONT}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Adamts5 (ADAM metallopeptidase with thrombospondin type 1 motif 5) [NCBI Gene 23794] {aka 9530092O11Rik, ADAM-TS5, ADAMTS1, ADAMTS11, ADMP-2, ASMP-2}, EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3) [NCBI Gene 9451] {aka PEK, PERK, WRS}, Trpc1 (transient receptor potential cation channel, subfamily C, member 1) [NCBI Gene 89821] {aka Trrp1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Casp1 (caspase 1) [NCBI Gene 25166] {aka Ice, Il1bc, p45}, COL2A1 (collagen type II alpha 1 chain) [NCBI Gene 1280] {aka ACG2, ANFH, ANFH1, AOM, COL11A3, EDMMD}, Sox9 (SRY-box transcription factor 9) [NCBI Gene 140586] {aka SRY}, SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, Sox9 (SRY (sex determining region Y)-box 9) [NCBI Gene 20682] {aka 2010306G03Rik, mKIAA4243, mSox9}, VIM (vimentin) [NCBI Gene 7431], Col10a1 (collagen, type X, alpha 1) [NCBI Gene 12813] {aka Col10, Col10a-1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, WNT10B (Wnt family member 10B) [NCBI Gene 7480] {aka SHFM6, STHAG8, WNT-12}
- **Diseases:** arthritis (MESH:D001168), chondrogenesis (MESH:C536017), osteoporosis (MESH:D010024), osteoarthritis (MESH:D010003), union (MESH:D017759), bone and cartilage defects (MESH:D002357), femoral condyle defect (MESH:D000092443), inflammation (MESH:D007249), injuries (MESH:D014947), fracture fusion (MESH:D000069337), bone fracture non (MESH:D050723), tumor (MESH:D009369), calcification (MESH:D002114), EMF (MESH:D007922)
- **Chemicals:** EGTA (MESH:D004533), calcium (MESH:D002118), calcium glycerophosphate (MESH:D005994), DBM-EO (-), glycosaminoglycan (MESH:D006025), MTT (MESH:C070243), titanium (MESH:D014025), dexamethasone (MESH:D003907), hydroxyapatite (MESH:D017886), water (MESH:D014867), polyaniline (MESH:C416807), tricalcium phosphate (MESH:C018392), staurosporin (MESH:D019311), iron (MESH:D007501), ascorbic acid (MESH:D001205), iron oxide (MESH:C000499), NO (MESH:D009569), cGMP (MESH:D006152), alginate (MESH:D000464), salts (MESH:D012492), polymer (MESH:D011108)
- **Species:** Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12939343/full.md

---
Source: https://tomesphere.com/paper/PMC12939343